Daesung Microbiological Labs, Inc. (036480) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Daesung Microbiological Labs, Inc. (036480:KRX), powered by AI.

Current Price
₩6,570
P/E Ratio
41.7
Market Cap
25.0B
Sector
Healthcare
What is the Daesung Microbiological Labs, Inc. stock price forecast?

Daesung Microbiological Labs, Inc. is currently trading at ₩6,570. View real-time AI analysis on Alpha Lenz.

What is Daesung Microbiological Labs, Inc. insider trading activity?

View the latest insider trading data for Daesung Microbiological Labs, Inc. on Alpha Lenz.

What is Daesung Microbiological Labs, Inc.'s P/E ratio?

Daesung Microbiological Labs, Inc.'s P/E ratio is 41.7.

Daesung Microbiological Labs, Inc.

KRX · 036480
₩6,570+140(+2.18%)Market closedKRX regular session 09:00–15:30 KST
Ask about Daesung Microbiological Labs, Inc.'s future dividend policy...
Alpha Chat Insight

Daesung Microbiological Labs, Inc. trades at a P/E of 41.7 (premium valuation) with modest ROE of 1.7%.

Ask for details

Company Overview

Daesung Microbiological Labs, Inc. is a leading entity in the biotechnology and microbiological sectors, specializing in the development and production of biological products. The company's primary function centers around the research and manufacturing of a broad spectrum of microbiology-based solutions, which are crucial for industries such as pharmaceuticals, agriculture, and environmental health. Known for its innovative approach, Daesung Microbiological Labs harnesses advanced biotechnological processes to create effective and sustainable products that support public health and industrial applications. Its offerings are instrumental in enhancing agricultural productivity, ensuring food safety, and providing therapeutic solutions. In the financial markets, Daesung Microbiological Labs, Inc. plays a significant role by contributing to the biotech sector's growth and development. Its robust research capabilities and product portfolio position it as a key player in advancing scientific solutions that address global challenges, marking its presence in both domestic and international markets.

CEO이동규, 이훈구 (각자대표)
SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

₩24,966,000,000Market Cap
₩25,988,810,010Revenue
3.80MShares Out
0Employees

Margins

24.77%Gross
13.34%EBITDA
2.75%Operating
1.29%Pre-Tax
2.30%Net

Valuation

41.74P/E
0.70P/B
0.96EV/Sales
11.97EV/EBITDA
23.73P/FCF

Growth (CAGR)

0.63%Rev 3Yr
0.94%Rev 5Yr
N/AOp Inc 3Yr
-20.09%Op Inc 5Yr
-29.45%Net Inc 3Yr
-17.00%Net Inc 5Yr

Returns

1.03%ROA
1.70%ROE
1.62%ROIC

Financial Health

₩3,445,716,530Cash & Cash Equivalents
₩19,112,026,220Net Debt
63.68%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Daesung Microbiological Labs, Inc. (ticker: 036480) is a company listed on KRX in the Healthcare sector (Biotechnology). Market cap is $25.0B.

The current price is ₩6,570 with a P/E ratio of 41.74x and P/B of 0.7x.

ROE is 1.70% and operating margin is 2.75%. Annual revenue is $26.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Daesung Microbiological Labs, Inc. (036480) Stock Forecast 2026 ₩6,570 — Price, Financials & Analyst Targets | Alpha Lenz